1,622
Views
0
CrossRef citations to date
0
Altmetric
Research Article

PPARG, GNG12, and CD19 are potential independent predictors of central nerve recurrence in childhood acute lymphoblastic leukemia

, , , , &
Article: 2182169 | Received 24 Oct 2022, Accepted 12 Feb 2023, Published online: 02 Mar 2023

References

  • Mueller KT, Maude SL, Porter DL, et al. Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia. Blood. 2017;130(21):2317–2325.
  • Ikonomidou C. Cerebrospinal fluid biomarkers in childhood leukemias. Cancers (Basel). 2021;13:438.
  • Saeedi A, Baghestani A, Khadem Maboudi A, et al. Determining the significant prognostic factors for the recurrence of pediatric acute lymphoblastic leukemia using a competing risks approach. Iran J Med Sci. 2020;45(4):304–310.
  • He GQ, Dai YL, Jiang MY, et al. Obesity as a prognostic factor of central nervous system relapse in children with acute lymphoblastic leukemia: a single-centre study and literature review. Evid Based Complement Alternat Med. 2022;2022: 7783823.
  • Kinjyo I, Bragin D, Grattan R, et al. Leukemia-derived exosomes and cytokines pave the way for entry into the brain. J Leukoc Biol. 2019;105(4):741–753.
  • Matloub Y, Lindemulder S, Gaynon PS, et al. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the children’s cancer group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the children’s oncology group. Blood. 2006;108(4):1165–1173.
  • Sirvent N, Suciu S, De Moerloose B, et al. CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: results of EORTC children leukemia group study 58951. Arch Pediatr. 2021;28(5):411–416.
  • Xu LH, Geng X, Liao N, et al. Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: a report from the south China children’s leukemia group. Front Oncol. 2022;12:943761.
  • Prieto C, López-Millán B, Roca-Ho H, et al. NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL. Leukemia. 2018;32(3):633–644.
  • Gossai NP, Gordon PM. The role of the central nervous system microenvironment in pediatric acute lymphoblastic leukemia. Front Pediatr. 2017;5:90.
  • Gaynes JS, Jonart LM, Zamora EA, et al. The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance. Haematologica. 2017;102(4):e136–e1e9.
  • Jaime-Pérez JC, Pinzón-Uresti MA, Jiménez-Castillo RA, et al. Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor. Hematology. 2018;23(1):1–9.
  • Jin MY, Han Y, Liu YJ, et al. [Treatment of central nervous system leukemia with CD19-chimeric antigen receptor T-cell immunotherapy: two cases report and literature review]. Zhonghua Xue Ye Xue Za Zhi. 2018;39(8):650–653.
  • Sherman BT, Hao M, Qiu J, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216–W221.
  • Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–Dd12.
  • Wang R, Ma H, Wang C. An ensemble learning framework for detecting protein complexes from PPI networks. Front Genet. 2022;13:839949.
  • Lenk L, Alsadeq A, Schewe DM. Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data. Cancer Metastasis Rev. 2020;39(1):173–187.
  • Janani C, Ranjitha Kumari BD. PPAR gamma gene–a review. Diabetes Metab Syndr. 2015;9(1):46–50.
  • Yousefnia S, Momenzadeh S, Seyed Forootan F, et al. The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity. Gene. 2018;649, 14-22.
  • Boyd A, Bhatia M. Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche. Nat Cell Biol. 2017;19(11):1336–1347.
  • Zhou F, Wen Y, Jin R, et al. New attempts for central nervous infiltration of pediatric acute lymphoblastic leukemia. Cancer Metastasis Rev. 2019;38(4):657–671.
  • Li J, Jin C, Zou C, et al. GNG12 regulates PD-L1 expression by activating NF-κB signaling in pancreatic ductal adenocarcinoma. FEBS Open Bio. 2020;10(2):278–287.
  • Langen UH, Ayloo S, Gu C. Development and cell biology of the blood-brain barrier. Annu Rev Cell Dev Biol. 2019;35: 591–613.
  • González-Mariscal L, Raya-Sandino A, González-González L, et al. Relationship between G proteins coupled receptors and tight junctions. Tissue Barriers. 2018;6:e1414015.
  • Yim YY, Betke KM, McDonald WH, et al. The in vivo specificity of synaptic Gβ and Gγ subunits to the α(2a) adrenergic receptor at CNS synapses. Sci Rep. 2019;9:1718.
  • Shi Q, Li M, Mika D, et al. Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes. Cardiovasc Res. 2017;113(6):656–670.
  • Fukuda S, Nakagawa S, Tatsumi R, et al. Glucagon-Like peptide-1 strengthens the barrier integrity in primary cultures of Rat brain endothelial cells under basal and hyperglycemia conditions. J Mol Neurosci. 2016;59(2):211–219.
  • Pacenta HL, Laetsch TW, John S. CD19 CAR T cells for the treatment of pediatric Pre-B cell acute lymphoblastic leukemia. Paediatr Drugs. 2020;22(1):1–11.
  • Maus MV, Grupp SA, Porter DL, et al. Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood. 2014;123(17):2625–2635.
  • Qi Y, Zhao M, Hu Y, et al. Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL. Blood. 2022;139(23):3376–3386.
  • Nair S, Wang JB, Tsao ST, et al. Functional improvement of chimeric antigen receptor through intrinsic interleukin-15Rα signaling. Curr Gene Ther. 2019;19(1):40–53.
  • Yao H, Price TT, Cantelli G, et al. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature. 2018;560(7716):55–60.
  • Gupta S, Teachey DT, Chen Z, et al. Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a children’s oncology group report. Cancer. 2022;128(9):1863–1870.
  • Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM study group . Blood. 2000;95(11):3310–3322.
  • Tevatia MS, Sharma I, Jadhav T, et al. Isolated CNS relapse in acute lymphoblastic leukemia (ALL): an experience from a tertiary care center. J Lab Physicians. 2021;13(2):134–138.